New Zealand markets closed

NVS Jan 2024 70.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
4.80000.0000 (0.00%)
As of 11:39AM EDT. Market open.
Full screen
Previous close4.8000
Open4.8000
Bid0.0000
Ask0.0000
Strike70.00
Expiry date2024-01-19
Day's range4.8000 - 4.8000
Contract rangeN/A
Volume5
Open interestN/A
  • Motley Fool

    Could This Biosimilar Drug Candidate Be a Hit for Novartis?

    On Sept. 19, Novartis (NYSE: NVS) shared positive news with investors regarding the clinical trial results for its biosimilar drug candidate to Amgen's (NASDAQ: AMGN) osteoporosis medicine Prolia. With Prolia set to lose exclusivity in the U.S. in 2025, Novartis could be close to booking some revenue from its biosimilar drug. Let's go over the outcome of the clinical trial and the U.S. osteoporosis market to figure this out.

  • Zacks

    NVS vs. RHHBY: Which Stock Should Value Investors Buy Now?

    NVS vs. RHHBY: Which Stock Is the Better Value Option?

  • Zacks

    Is Novartis (NVS) a Great Value Stock Right Now?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.